Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia

Oral HRS-7535 shows promise in glycaemic control for T2D patients
16 Oct 2026
bởiStephen Padilla
Use of the once-daily oral HRS-7535, an investigational small-molecule GLP-1 receptor agonist (RA) for type 2 diabetes (T2D) and weight management, demonstrates noninferiority to dapagliflozin for glycated haemoglobin (HbA1c) reduction in Chinese adults with T2D, results of the OUTSTAND-2 phase III trial have shown. Treatment differences are also in favour of HRS-7535, with superiority at the 90-mg dose.
16 Oct 2026

Antidepressant effect on QTc interval varies among adults with depression
13 Oct 2026
bởiStephen Padilla
Use of antidepressants are generally safe in terms of heart rate corrected QT interval (QTc) prolongation, but differences exist across antidepressants and risk factors among adults with major depressive disorder, according to a study.
13 Oct 2026






